We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INAC:NASDAQIndigo Acquisition Corp. Analysis

Data as of 2026-05-25 - not real-time

$10.21

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Indigo Acquisition Corp. (INAC) is trading at $10.21, just above its 20‑day SMA of $10.19 and 50‑day SMA of $10.17, indicating short‑term price alignment with recent trends. The MACD line sits marginally above its signal line, generating a bullish signal, while the RSI at 57.7 suggests modest upward momentum without being overbought. Support at $10.15 and resistance near $10.24 frame a narrow trading range, and decreasing volume raises questions about sustained interest. The stock’s beta is essentially neutral (-0.01) and 30‑day volatility is low at ~2.1%, implying limited price swings, yet the market cap of $150M and average daily volume of under 1,000 shares highlight a liquidity constraint. Fundamentally, INAC reports zero revenue, negative book value per share (-$0.225), and a high trailing PE of 36.5 versus an industry average of 16.8, pointing to an overvalued valuation for a shell company with no operating earnings. Recent news of separate trading of ordinary shares and rights adds a procedural layer but does not materially improve the underlying business outlook. Overall, the technical setup is mildly bullish, but fundamental and liquidity factors suggest caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and RSI just below overbought levels
  • Narrow price range with support near current price
  • Decreasing volume indicating waning short‑term interest

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Overvalued PE relative to sector peers
  • Zero revenue and negative book value
  • Liquidity constraints due to low average daily volume

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Lack of operating business and earnings
  • Potential dilution from rights trading and future SPAC activities
  • High valuation multiples without fundamental support

Key Metrics & Analysis

Financial Health

P/E Ratio36.5
P/B Ratio-45.4
Op. Cash Flow$-658552
Industry P/E16.8

Technical Analysis

TrendBullish
RSI57.7
Support$10.15
Resistance$10.24
MA 20$10.19
MA 50$10.17
MA 200$10.07
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta-0.01
Volatility2.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.